5311.0: Wednesday, November 15, 2000: 8:30 PM-10:00 PM | ||||
| ||||
| The session will review some key advances made in responding effectively to the resurgent tuberculosis epidemic. Ms. Diana Weil, WHO/World Bank, will present on the objectives and progress of the Stop TB Initiative, a partnership to confront the TB epidemic (or Dr. A. Kochi, Director, Stop TB Initiative will present); Drs. Solange Cavalcante and Paula Fujiwara will present "a tale of two cities" on how the recommended DOTS strategy is/was launched in these complex settings of Rio de Janeiro and New York City. Drs. Cavalcante and Fujiwara are Directors of TB Control for their respective cities. Dr. Richard Laing (BU School of Public Health) will present on trends in pricing of anti-TB drugs, essential for DOTS success. Dr. Jim Kim (Harvard School of Medicine) will present on the challenge and response to rising mulit-drug resistant disease, including launching of the "DOTS-Plus" approach | ||||
| See individual abstracts for presenting author's disclosure statement. | ||||
| Learning Objectives: Refer to the individual abstracts for learning objectives | ||||
| Amy Bloom, MD | ||||
| Framework for implementing communicable disease programs within changing health systems Diana Weil, Tazim Mawji | ||||
| Tuberculosis drug prices Richard Laing, MBChB MSc MD, Kelly McGoldrick, MPH | ||||
| Making DOTS-Plus Work: Lowering Cost and Increasing Control of 2nd-line Anti-tuberculous Medications Jim Yong Kim, MD, PhD, Rajesh Gupta, MPH, Mario Raviglione, MD | ||||
| Overcoming Obstacles to Tuberculosis Control Paula Fujiwara, MD | ||||
| Sponsor: | International Health | |||
| Cosponsors: | Caucus on Refugee and Immigrant Health; Latino Caucus | |||